Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07455539) titled 'LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Prince of Wales Hospital, Shatin, Hong Kong
Condition:
Non Valvular Atrial Fibrillation
Intervention:
Device: LAmbre II Left Atrial Appendage Occluder
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 1, 2026
Target Sample Size: 10
To know more, visit https://cli...